There is an ancient reflex in us — when the skin cries out, the hand answers. Researchers at the University of Pittsburgh have now traced exactly why that answer makes things worse: scratching activates pain pathways that summon immune cells through a second, separate route, turning a fleeting irritation into a prolonged inflammatory siege. The body, it seems, is trying to protect itself and inadvertently prolonging its own suffering — a small but telling parable about the limits of instinct.
Why Scratching That Bug Bite Makes It Worse, According to Science
Cobertura Relacionada
Wales' only two-Michelin-star restaurant regained its five-star food hygiene rating after addressing violations includin…
BBC News · Aug 06 Loophole allows car washes and vape shops to sponsor foreign workers despite visa tighteningOver 1,900 small high-street businesses including car washes and vape shops retain licenses to sponsor skilled foreign w…
Newswise · Aug 06 Neuroimaging reveals how systemic diseases reshape brain structure and functionNeuroimaging studies demonstrate that systemic diseases profoundly affect brain structure and function, while brain diso…
Esquire Singapore · Aug 06 Five Watches Built to Last: Modern Designs Destined to Become ClassicsEsquire Singapore highlights five new watch models from luxury brands that prioritize timeless design over trends, featu…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
This article discusses dermatological research on itching mechanisms and has no geopolitical implications.
Lente Econômica
Scientific research on itch-scratch cycles has minimal direct economic impact; primarily affects dermatology and over-the-counter anti-itch product markets with modest consumer awareness implications.
Consumers may increase purchases of anti-itch creams and menthol treatments based on scientific validation of dermatologist recommendations, potentially shifting spending from scratching-based relief to topical products. Impact is marginal as these products are already widely available.
Minimal regulatory implications. May support existing FDA guidance on OTC anti-itch treatments and dermatology best practices. Could inform public health messaging about skin care, though this is routine medical information.